RACHEL RETHERFORD: Open Payments
NPI 1669017117 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 63 payments from 16 companies in 2025. Trend: 2023 $1,049 · 2024 $1,409 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $272 |
| Novo Nordisk Inc | 9 | $246 |
| AstraZeneca Pharmaceuticals LP | 9 | $242 |
| Alexion Pharmaceuticals, Inc. | 1 | $129 |
| PFIZER INC. | 5 | $107 |
| Gilead Sciences, Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $65 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
Products named: AIRSUPRA, Wegovy, QULIPTA, BREZTRI, UBRELVY, MOUNJARO, VRAYLAR, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
